Skip to main content
. 2020 Jul 16;138(9):935ā€“942. doi: 10.1001/jamaophthalmol.2020.2443

Figure 3. Treatments Received Up to Month 24 in the Combination and Monotherapy Groups.

Figure 3.

Data on the full analysis set are shown. A, Percentages are based on the total number of participants in the respective treatment group, with 168 in the combination treatment group and 154 in the monotherapy group. B, Percentages are based on the total number of participants in the combination treatment group (nā€‰=ā€‰168). vPDT indicates verteporfin photodynamic therapy.